BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1804040)

  • 1. Nitrogranulogen-dependent inhibition of antibody synthesis. I. In vitro studies in man.
    Wasik M; Stepień-Sopniewska B; Kozakiewicz A; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):117-20. PubMed ID: 1804040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrogranulogen-dependent inhibition of antibody synthesis. II. In vivo studies in mice.
    Lagodziński Z; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):121-5. PubMed ID: 1804041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogranulogen: a strong inhibitor of human lymphocyte proliferation.
    Wasik M; Górski A
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):49-54. PubMed ID: 2619509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFX modulates the immunosuppressive effect of cyclophosphamide on antibody production in mice.
    Paczek L; Gaciong Z; Górski A; Lagodziński Z; Brzezny M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):415-9. PubMed ID: 2639638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin: an immunomodulator of antibody production in man.
    Górski A; Korczak-Kowalska G; Nowaczyk M; Gaciong Z; Skopińska-Rózewska E
    Immunology; 1982 Nov; 47(3):497-501. PubMed ID: 6215339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 7. [The immunobiological effects of nitrogranulogen. I. Summarizing the results of the immunological studies to date].
    Górski A; Wasik M; Nowaczyk M; Stepień-Sopniewska B
    Pol Arch Med Wewn; 1991 Aug; 86(2):65-7. PubMed ID: 1775392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.
    Stevenson HC; Fauci AS
    Immunology; 1980 Mar; 39(3):391-7. PubMed ID: 7002766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive drugs inhibit class II antigen (HLA-D) synthesis by B and T lymphocytes.
    Nowaczyk M; Pluta A; Modlińska M; Bukowska J; Górski A
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):415-9. PubMed ID: 2130806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
    Fidler JM; DeJoy SQ; Gibbons JJ
    J Immunol; 1986 Jul; 137(2):727-32. PubMed ID: 3487580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action.
    Rosenthal GJ; Weigand GW; Germolec DR; Blank JA; Luster MI
    J Immunol; 1988 Jul; 141(2):410-6. PubMed ID: 2968399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cyclophosphamide derivatives on cellular cytotoxicity (NK, ADCC) in vitro.
    Wasik M; Rychlik G; Górski A
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):259-65. PubMed ID: 2102658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lindane exposure on rainbow trout (Oncorhynchus mykiss) immunity. II. In vitro restoration of antibody-secreting cells and lymphocyte proliferation activity by nitrogranulogen after in vivo immunosuppression due to lindane.
    Siwicki AK; Dunier M
    Ecotoxicol Environ Saf; 1994 Apr; 27(3):316-23. PubMed ID: 7519550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the immunosuppressive properties of Sch 24937.
    Smith SR; Terminelli C; Epps S; Watnick A; Umland S
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):333-59. PubMed ID: 2963854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tumour promoter phorbol myristate acetate on mouse lymphocytes: selective inhibition of B cell activation by mitogens and antigens.
    Hawrylowicz CM; Klaus GG
    Immunology; 1984 Feb; 51(2):327-32. PubMed ID: 6607211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):221-37. PubMed ID: 8292971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interferon-alpha on immunoglobulin synthesis by human B cells.
    Peters M; Ambrus JL; Zheleznyak A; Walling D; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3153-7. PubMed ID: 3021846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FK 506 on B-cell responses.
    Lagodziński Z; Górski A; Stepień-Sopniewska B; Wasik M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):942-3. PubMed ID: 1703359
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of thymosin on human blood lymphocytes in vitro].
    Kosmiadi GA; Grigor'eva MP; Korotaev GK; Il'intseva IE; Grigor'ev MIu
    Vopr Onkol; 1979; 25(10):7-11. PubMed ID: 315663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.
    Peters M; Walling DM; Kelly K; Davis GL; Waggoner JG; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3147-52. PubMed ID: 3490513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.